Justification of the tasks of the register of military personnel, affected by SARS-CoV-2


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Аbstract. The current regulatory framework of the Ministry of Health and the Ministry of Defense of the Russian Federation on the regulation of the provision of medical assistance to military personnel affected by the infection caused by the SARS-CoV-2 coronavirus is considered. The state of the problem of information support for the provision of medical care to military personnel of this category is assessed. The developed methodology and the draft regulatory document for organizing the collection of medical information in the register of military personnel affected by the infection caused by the SARS-CoV-2 coronavirus are presented, and a regulation on this register is developed. The content, scope and algorithm of creating an information-analytical system for registering this pathology among military personnel, as well as the need to introduce new medical document management technologies into the medical service of the Armed Forces of Russia based on personified records of military personnel and the medical and psychological assistance provided to them, are substantiated. It is shown that for the smooth functioning of the register within the framework of a justified list of tasks, the presence of high-speed secure communication channels between the participating military units, institutions and medical service management bodies will be required. Consequently, the improvement of the information support system for managing the medical support of troops in peacetime and wartime is an important component of increasing the effectiveness of managing medical support for military.

作者简介

G. Zagorodnikov

Military medical academy of S.M. Kirov

编辑信件的主要联系方式.
Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

I. Uliukin

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

E. Orlova

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

A. Sechin

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

V. Reznik

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

A. Shuklina

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

S. Telitskiy

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

D. Ovchinnikov

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

V. Tegza

Military medical academy of S.M. Kirov

Email: vmeda-nio@mil.ru
俄罗斯联邦, Saint Petersburg

参考

  1. Временные алгоритмы по ведению пациентов с новой коронавирусной инфекцией COVID-19 в перепрофилированных клиниках академии. Версия 1.0 (25.04.2020 г.). – СПб.: ВМедА, 2020. – 20 с.
  2. Временные методические рекомендации: профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 8 (03.09.2020). – М.: 2020. – 227 с.
  3. Гончарук, Е.И. Изучение свойств коронавирусов обезьян / Е.И. Гончарук [и др.] // Вопр. вирусолог. – 1993. – № 3. – C. 126–129.
  4. Горичный, В.А. Подходы к обоснованию задач регистра инфекционной патологии и инфицированных вирусом иммунодефицита человека военнослужащих / В.А. Горичный [и др.] // Вест. Росс. воен.-мед. акад. – 2017. – №2 (58). – С. 171–174.
  5. Диагностика, лечение и профилактика новой коронавирусной инфекции (COVID-19). Методические рекомендации (версия 4 от 06.04.2020 г.). – М.: ГВМУ МО РФ, 2020. – 54 с.
  6. Информационный бюллетень МО РФ по недопущению распространения новой коронавирусной инфекции (на 5.09.2020 г.). – М., 2020. – 3 с.
  7. Короваева, И.В. Новый коронавирус – возбудитель атипичной пневмонии / И.В. Короваева, С.И. Вовк, Л.А. Панченко // Аннали Мечниковського інституту. – Харьков, 2005. – № 1, – С. 66–74.
  8. Осидак, Л.В. Коронавирусная инфекция (этиология, эпидемиология, клинико-лабораторная характеристика, противовирусная терапия). Пособие для врачей / Л.В. Осидак [и др.]. – СПб.: Человек, 2007. – 64 с.
  9. Arbour, N. Persistent infection of human oligodendrocytic and neuroglial cell lines by Human Coronavirus 229E / N. Arbour [et al.] // J. Virol. – 1999. – Vol. 73, № 4. – P. 3326–3337.
  10. Asadi-Pooyaa, A.A. Central nervous system manifestations of COVID-19: A systematic review / A.A. Asadi-Pooyaa, L. Simanic // J. Neurol. Sci. – 2020. – № 413. – P. 116832.
  11. Bohmwald, K. Neurologic Alterations Due to Respiratory Virus Infections / K. Bohmwald [et al.] // Front. Cell Neurosci. – 2018. – № 12. – Р. 386.
  12. Baig, A.M. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms / A.M. Baig [et al.] // ACS Chem. Neurosci. – 2020. – Vol. 11, № 7. – Р. 995–998.
  13. Chan-Yeung, M. Severe acute respiratory syndrome (SARS) and healthcare workers / M. Chan-Yeung // Int. J. Occup. Environ. Health. – 2004. – Vol. 10, № 4. – P. 421–427.
  14. Cheng, Y. Kidney disease is associated with in-hospital death of patients with COVID-19 / Y. Cheng [et al.] // Kidney Int. – 2020. – Vol. 97, № 5. – P. 829–838.
  15. Das, K.M. Middle east respiratory syndrome coronavirus: what does a radiologist need to know? / K.M. Das [et al.] // Am. J. Roentgenol. – 2016. – Vol. 206, № 6. – P. 1193–201.
  16. Hamre, D. A new virus isolated from the human respiratory tract / D. Hamre, J J. Procknow // Proc. Soc. Exp. Biol. Med. – 1966. – Vol. 121, № 1. – P. 190–193.
  17. International guidelines for certification and classification (coding) of COVID-19 as cause of death. Based on ICD International Statistical Classification of Diseases (16 April 2020). – Geneva: WHO, 2020. – 14 р.
  18. Li, Y.C. Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells / Y.C. Li [et al.] // Virus Res. – 2012. – Vol. 163, № 2. – Р. 628–635.
  19. Moriguchi, T. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 / T. Moriguchi [et al.] // Int. J. Infect. Dis. – 2020. – Vol. 94. – P. 55–58.
  20. Müller, N.L. Severe acute respiratory syndrome: radiographic and CT findings / N.L. Müller [et al.] // Am. J. Roentgenol. – 2003. – Vol. 181, № 1. – P. 3–8.
  21. Tian, Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission / Y.Tian [et al.] // Aliment. Pharmacol. Ther. – 2020. – Vol. 51, № 9. – Р. 843–851.
  22. Tyrrell, D.A. Cultivation of «difficult» viruses from patients with common colds / D.A. Tyrrell, M.L. Bynoe, B. Hoorn // Brit. Med. J. – 1968. – Vol. 1, № 5592. – P. 606–610.
  23. Vollono, C. Focal status epilepticus as unique clinical feature of COVID-19: A case report / C. Vollono [et al.] // Seizure. – 2020. – № 78. – Р. 109–112.
  24. Weiss, S.R. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus / S.R. Weiss, S. Navas-Martin // Microbiol. Mol. Biol. Rev. – 2005. – Vol. 69, № 4. – Р. 635–664.
  25. Wu, F. A new coronavirus associated with human respiratory disease in China / F. Wu [et al.] // Nature. – 2020. – Vol. 579, № 7798. – Р. 265–269.
  26. Xu, S. Beware of the second wave of COVID-19 / S. Xu, Y. Li // Lancet. – 2020. – Vol. 395, № 10233. – Р. 1321–1322.
  27. Yang, W. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China / W. Yang [et al.] // J. Infect. – 2020. – Vol. 80, № 4. – Р. 388–393.
  28. Zhang, L. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by «on the scene» cardiologists / L. Zhang, Y. Fan, Z. Lu // Eur. Heart J. – 2020. – Vol. 41, № 19. – Р. 1788–1790.

版权所有 © Zagorodnikov G.G., Uliukin I.M., Orlova E.S., Sechin A.A., Reznik V.M., Shuklina A.A., Telitskiy S.Y., Ovchinnikov D.V., Tegza V.Y., 2020

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

##common.cookie##